GBT Guerbet SA

GUERBET : Financial agenda for 2026

GUERBET : Financial agenda for 2026

Financial agenda for 2026

Villepinte, November 19, 2025: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2026.

Publications calendar
  • 2025 ANNUAL REVENUE
February 05, 2026, after trading
  • 2025 ANNUAL RESULTS
March 11, 2026, after trading
  • 2026 1ST QUARTER REVENUE
April 23, 2026, after trading
  • ANNUAL SHAREHOLDERS’ MEETING
May 22, 2026
  • 2026 2ND QUARTER REVENUE
July 23, 2026, after trading
  • 2026 FIRST HALF RESULTS
September 15, 2026, after trading
  • 2026 3RD QUARTER REVENUE
October 22, 2026, after trading

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. As pioneers in contrast products for 98 years, with more than 2,905 employees worldwide, we continuously innovate and devote 9% of our revenue to Research and Development in four centers in France and the United States. Guerbet (GBT) is listed in compartment B of Euronext Paris and generated revenue of €841m in 2024. For more information, please visit .



Contacts:

Guerbet     

Christine Allard, SVP Public Affairs and Corporate Communications 82 /

Seitosei.Actifin                                                                                       

Marianne Py, Financial Communication 93 /

Anne-Claire Taton, Press 18 /

Attachment



EN
19/11/2025

Underlying

GBTGuerbet SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Guerbet SA

 PRESS RELEASE
Free
GBT GUERBET SA

GUERBET : Nombre d'actions et de droits de vote composant le capital d...

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2026 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les sociétés dont des actions sont admises aux négociations sur un marché réglementé publient sur leur site Internet et transmettent à l’AMF, à la fin de chaque mois, le nombre total de droits de vote et le nombre d’actions composant le capital de la société s’ils ont varié par ra...

February 20, 2026 1 EN
Aurelien Sivignon ... (+2)
  • Aurelien Sivignon
  • Thomas Zlowodzki
LUFTHANSA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BEKB BEKAERT SA
ALLIX WALLIX GROUP SA
APAML APERAM SA
PHA PHARMAGEST INTERACTIVE SA
IAG INTERNATIONAL CONSOLIDATED AIRLINES GROUP SA
NRG NRJ GROUP SA
LNA LNA SANTE SA
GBT GUERBET SA
WIZZ WIZZ AIR HOLDINGS PLC
EZJ EASYJET PLC
RY4C RYANAIR HOLDINGS PLC
SAVE SAVENCIA SA
LIGHT SIGNIFY NV
XFAB X-FAB SILICON FOUNDRIES SE
DUFN DUFRY AG
ALD ALD SA
OBEL ORANGE BELGIUM SA
NVM NOVEM GROUP SA
AF AIR FRANCE - KLM
02/06/26 February 6, 2026 1 EN
Aurelien Sivignon ... (+2)
  • Aurelien Sivignon
  • Thomas Zlowodzki
LUFTHANSA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BEKB BEKAERT SA
ALLIX WALLIX GROUP SA
APAML APERAM SA
PHA PHARMAGEST INTERACTIVE SA
IAG INTERNATIONAL CONSOLIDATED AIRLINES GROUP SA
NRG NRJ GROUP SA
LNA LNA SANTE SA
GBT GUERBET SA
WIZZ WIZZ AIR HOLDINGS PLC
EZJ EASYJET PLC
RY4C RYANAIR HOLDINGS PLC
SAVE SAVENCIA SA
LIGHT SIGNIFY NV
XFAB X-FAB SILICON FOUNDRIES SE
DUFN DUFRY AG
ALD ALD SA
OBEL ORANGE BELGIUM SA
NVM NOVEM GROUP SA
AF AIR FRANCE - KLM
02/06/26 February 6, 2026 1 FR
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
02/06/26 February 6, 2026 1 EN
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
02/06/26 February 6, 2026 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch